Abstract
This chapter provides a historical reference, covers the progression in the scientific and technological development, highlights the contemporary aspects, and describes the application of the current USFDA guidance to the development through commercial life cycle for lyophilized products. Considerations of designing formulations, including the use of organic solvents, and influence of packaging are noted. Emphasis is placed on the engineering of the lyophilization process, establishing the critical process parameters, and defining of the critical quality attributes. Utility of applying the US FDA process analytical technology initiative, as well as the notion of applying design space principles to the lyophilization process is included, leading into discussions on applying the current USFDA guideline on process validation to the development and manufacturing. Current challenges and unique aspects in development of lyophilized products are also highlighted, including poorly soluble drug substances, novel delivery systems, improving manufacturing capabilities, and reducing unit costs for world wide product distribution. This presentation encompasses the progression of the technological developments, reviews current thinking on the science and technology, and highlights contemporary approaches to the development and manufacturing of lyophilized parenterals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
An independent variable is those that are under direct control and are not resulting from influencing factors or dependent upon other processing variables.
References
Bosch AM, Shultz CA (2008) Freeze drying of pharmaceuticals and biologicals conference, Breckenridge, CO
Bursac R, Sever R, Hunek B (2009) A practical method for resolving the nucleation problem in lyophilization. Bio Process Int 7:66–72
Byron PR, DeLuca PP, Twonsend MW (1990) The effects of formulation additives on the degradation of freeze dried ribonuclease A. Pharm Res 7:1086–1091
Cannon TC, Shemeley KA (2004) Statistical evaluation of vial design features that influence sublimation rates during primary drying. Pharm Res 21:536–542
Cannon TC, Trappler EH (2000) Influence of lyophilization on the polymorphic behavior of mannitol. PDA J Pharm Sci Technol 54(1):13–22
Chapman K (1984) The PAR approach to process validation. Pharm Technol 4:47–54
DeLuca PP, Kasrain K (1995) The effect of tertiary butyl alcohol on the resistance of the dry product layer during primary drying. Pharm Res 12:491–495
Deluca P, Lachman L (1965) Lyophilization of pharmaceuticals. I: Effects of certain physical-chemical properties. J Pharm Sci 54:617–624
Evans SA, Morris KR, MacKenzie AP, Lordi NG (1995) Dielectric characterization of thermodynamic first order events in model frozen systems intended for lyophilization. PDA J Pharm Sci Technol 49:1–8
Fang WJ, Qi W, Prestrelski S, Carpenter JF (2012) Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations. Pharm Res 29:3278–3291
Fitzpartick S, Saklatvala R (2003) Understanding the physical stability of freeze-dried dosage form from the glass transition temperature of the amorphous components. J Pharm Sci 92:2504–2510
Flamberg DE, Francis DL, Morgan SL, Wicks GF (1970) Low temperature vacuum drying of sterile parenterals from ethanol. Bull Parenter Drug Assoc 24:210–217
Food and Drug Administration (1993) Guide to Inspection of Lyophilization of Parenterals, FDA, July 1993 http://ww.fda.gov/ICECI/Inspections/InspectionGuides /ucm074909.htm
Food and Drug Administration (2011) Guidance for Industry Process Validation: General Principles and Practices, FDA, January 2011. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryinformation/Guidances/default.htm
Gieseler H, Kessler W, Finson M, Davis S, Mulhall P, Bons V, Debo D, Pikal MJ (2007) Evaluation of tunable diode laser absorption spectroscopy for in-process water vapor mass flux measurements during freeze drying. J Pharm Sci 96:1776–1793
Ginnette LF, Graham RP, Morgan AI (1958) Freeze drying rates. In: Vacuum symposium transactions, fifth national symposium on vacuum technology transitions, Pergamon Press, NY
Hora MS, Wolfe SN (2004) Critical steps in the preparation of elastomeric closures for biopharmaceutical freeze dried products. Marcel Dekker, New York
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2009) Pharmaceutical development Q8(R2)
Johnson R, Muhvich K, Tidswell E, Trappler EH (2012) Current sterile and lyo is discussed at joint IG session. PDA Letter XLVIII:3847. Parenteral Drug Association, Bethesda, MD www.pda.org/pdaletter
Kaifman S, Novara M, Potter C, Sadowski P (2012) Self-administration of injectables. BioPharm Int 4:42–48
Konstantinidis AK, Kuu W, Otten L, Nail SL, Sever RR (2011) Controlled nucleation in freeze-drying: effect on pore size in the dried product layer, mass transfer resistance, and primary drying rate. J Pharm Sci 100(8):3453–3470. doi:10.1002/jps.22561
Korey DJ, Schwartz JB (1989) Effects of excipients on the crystallization of pharmaceutical compounds during lyophilization. J Parenter Sci Technol 43:80–83
Landsberg (1956), Proceedings, Vacuum Symposium Transactions, Continuous Analysis of Gasses in a High Vacuum Furnace with a Monitoring Mass Spectrometer, Committee on Vacuum Techniques, American Vacuum Society, Boston
Milton N, Pikal MJ, Roy ML, Nail SL (1997) Evaluation of manometric temperature measurement as a method on monitoring product temperature during lyophilization. PDA J Pharm Sci Technol 51:7–16
Nail S (1980) Effect of chamber pressure on heat transfer in the freeze drying of parenteral solutions. J Parenter Sci Technol 5:358–368
Nail SL, Johnson W (1991) Methodology for in-process determination of residual water in freeze-dried products. Dev Boil Stand 44:137–151
Patel SM, Bhugra C, Pikal MJ (2009) Reduced pressure ice fog technique for controlled ice nucleation during freeze-drying. AAPS PharmSciTech 10:1406–1411
Pikal MJ, Roy ML (1989) Process control in freeze drying: determination of the end point of sublimation drying by an electronic moisture sensor. J Parenter Sci Technol 44:60–66
Pikal MJ, Shah S, Senior D, Lang JE (1983) Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique. J Pharm Sci 72:635–650
Pikal MJ, Roy ML, Shah S (1984) Mass and heat transfer in vial freeze drying of pharmaceuticals: role of the vial. J Pharm Sci 73:1224–1237
Pikal MJ, Shah S, Roy ML, Putman R (1990) The secondary drying stage of freeze drying: drying kinetics as a function of temperature and chamber pressure. Int J Pharm 60:203–217
Seager H, Taskis M, Syrop M, Lee TJ (1985) Structure of products prepared by freeze-drying solutions containing organic solvents. J Parenter Sci Technol 39:161–179
Searles JA, Carpenter JF, Randolph TW (2001) Annealing to optimize the primary drying rate, reduce freeze-induced drying rate heterogeneity, and determine Tg’ in pharmaceutical lyophilization. J Pharm Sci 90:872–887
Stark J (1998) Blood. Pretence-Hall, New York
Teagarden DL, Baker DS (2002) Practical aspects of lyophilization using non-aqueous co-solvent systems. J Pharm Sci 15:115–133
Trappler EH (2004) Validation of lyophilization: equipment and process. In: Constantino H, Pikal MJ (eds) Lyophilization of biopharmaceuticals. AAPS Press, Arlington, VA
Trappler (2011) Proceedings, International Society of Lyophilization – Freeze Drying Midwest Chapter Annual Meeting, April, 2011
Trappler EH, Mutchler AM, Day LA (2012) Effect of vial construction on performance and product temperature during freezing and freeze drying. In: Freeze drying of pharmaceuticals and biologicals conference, Breckenridge, CO
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Trappler, E.H. (2013). Contemporary Approaches to Development and Manufacturing of Lyophilized Parenterals. In: Kolhe, P., Shah, M., Rathore, N. (eds) Sterile Product Development. AAPS Advances in the Pharmaceutical Sciences Series, vol 6. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7978-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7978-9_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7977-2
Online ISBN: 978-1-4614-7978-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)